Effective Management of Major Lower Extremity Wounds Using an Acellular Regenerative Tissue Matrix: A Pilot Study
Authors:
- Steven F BocSBSteven F Boc
- Ramon C LopezRLRamon C Lopez
- 1 January 2004
- journal article
- clinical trial
- Published by SLACK, Inc. in Orthopedics
- Vol. 27 (1) , S145-S149
Abstract
Wound healing is a significant problem in orthopedics. Graftjacket tissue matrix (Wright Medical Technology, Ine, Arlington, Tenn), a novel acellular regenerative tissue matrix, has been designed to aid wound closure. A prospective, randomized study was initiated to determine the efficacy of this tissue product in wound repair compared with conventional treatment. Lower extremity wounds are refractile to healing in patients with diabetes mellitus. Therefore, researchers used diabetic foot ulcers to evaluate the efficacy of Graftjacket tissue matrix in wound repair. Only a single administration of the tissue matrix was required. After 1 month of treatment, preliminary results demonstrate that this novel tissue matrix promotes faster healing at a statistically significant rate over conventional treatment. Because wounds in this series of patients are deep and circulation around the wound is poor, the preliminary results suggest that this tissue matrix will be applicable to other types of orthopedic wounds.Keywords
This publication has 9 references indexed in Scilit:
- Percent Change in Wound Area of Diabetic Foot Ulcers Over a 4-Week Period Is a Robust Predictor of Complete Healing in a 12-Week Prospective TrialDiabetes Care, 2003
- Diabetic Neuropathic Foot UlcersDiabetes Care, 2002
- Blood flow changes in diabetic foot ulcers treated with dermal replacement therapyThe Journal of Foot and Ankle Surgery, 2002
- Off-Loading the Diabetic Foot WoundDiabetes Care, 2001
- Graftskin, a Human Skin Equivalent, Is Effective in the Management of Noninfected Neuropathic Diabetic Foot UlcersDiabetes Care, 2001
- The effects of ulcer size and site, patient's age, sex and type and duration of diabetes on the outcome of diabetic foot ulcersDiabetic Medicine, 2001
- A bilayered living skin construct (APLIGRAF®) accelerates complete closure of hard‐to‐heal venous ulcersWound Repair and Regeneration, 1999
- A Metabolically Active Human Dermal Replacement for the Treatment of Diabetic Foot UlcersArtificial Organs, 1997
- Use of Dermagraft, a Cultured Human Dermis, to Treat Diabetic Foot UlcersDiabetes Care, 1996